JP2012524120A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012524120A5 JP2012524120A5 JP2012507283A JP2012507283A JP2012524120A5 JP 2012524120 A5 JP2012524120 A5 JP 2012524120A5 JP 2012507283 A JP2012507283 A JP 2012507283A JP 2012507283 A JP2012507283 A JP 2012507283A JP 2012524120 A5 JP2012524120 A5 JP 2012524120A5
- Authority
- JP
- Japan
- Prior art keywords
- derivative
- derivatives
- biologically active
- peptides
- proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004480 active ingredient Substances 0.000 claims 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 claims 2
- 239000002777 nucleoside Substances 0.000 claims 2
- 125000003729 nucleotide group Chemical group 0.000 claims 2
- 210000001539 phagocyte Anatomy 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 229940064005 Antibiotic throat preparations Drugs 0.000 claims 1
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 claims 1
- 229940042052 Antibiotics for systemic use Drugs 0.000 claims 1
- 229940042786 Antitubercular Antibiotics Drugs 0.000 claims 1
- 229940093922 Gynecological Antibiotics Drugs 0.000 claims 1
- 108010013639 Peptidoglycan Proteins 0.000 claims 1
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 claims 1
- 229940029983 VITAMINS Drugs 0.000 claims 1
- 229940021016 Vitamin IV solution additives Drugs 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 230000001387 anti-histamine Effects 0.000 claims 1
- 102000004965 antibodies Human genes 0.000 claims 1
- 108090001123 antibodies Proteins 0.000 claims 1
- 239000000739 antihistaminic agent Substances 0.000 claims 1
- 230000003078 antioxidant Effects 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 230000003115 biocidal Effects 0.000 claims 1
- 229920001222 biopolymer Polymers 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 239000002158 endotoxin Substances 0.000 claims 1
- 229960001340 histamine Drugs 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 229940079866 intestinal antibiotics Drugs 0.000 claims 1
- 150000002500 ions Chemical class 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 101700049451 lppL Proteins 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 239000003607 modifier Substances 0.000 claims 1
- 229910052755 nonmetal Inorganic materials 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 150000003833 nucleoside derivatives Chemical class 0.000 claims 1
- 125000003835 nucleoside group Chemical group 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 claims 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 claims 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 claims 1
- 125000003396 thiol group Chemical class [H]S* 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 229930003231 vitamins Natural products 0.000 claims 1
Claims (1)
- 生物学的に活性な組成物であって、
(a)以下の生物学的に活性な成分:
(i)核酸又はその誘導体、
(ii)ヌクレオシド、ヌクレオチド、又はヌクレオシド若しくはヌクレオチドの誘導体、
(iii)ペプチド、タンパク質、又はペプチド若しくはタンパク質の誘導体、
(iv)リポ多糖又はその誘導体、
(v)ペプチドグリカン又はその誘導体、
(vi)炭水化物又はその誘導体、
(vii)脂質又はその誘導体、
(viii)リポペプチド又はその誘導体、
(ix)金属イオン、
(x)チオール、
(xi)抗生物質又はその誘導体、
(xii)ビタミン又はその誘導体、
(xiii)バイオフラボノイド又はその誘導体、
(xiv)抗酸化物質又はその誘導体、
(xv)免疫応答修飾因子、
(xvi)抗体、
(xvii)生物学的に活性な非金属、
(vxiii)ヒスタミン又は抗ヒスタミン剤、及び
(xix)キナーゼ阻害剤
のうち少なくとも1種と
(b)前記組成物を食細胞に送達し、その結果、生物学的に活性な成分が、食細胞によって取り込まれ、その生物活性に影響を及ぼすのに有効な少なくとも1種の生体高分子の担体と
を含む上記組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17094509P | 2009-04-20 | 2009-04-20 | |
US61/170,945 | 2009-04-20 | ||
PCT/US2010/031559 WO2010123798A2 (en) | 2009-04-20 | 2010-04-19 | Compositions for transfection of biomolecules into cells |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015171776A Division JP6295235B2 (ja) | 2009-04-20 | 2015-09-01 | 生体分子を細胞へトランスフェクトするための組成物 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2012524120A JP2012524120A (ja) | 2012-10-11 |
JP2012524120A5 true JP2012524120A5 (ja) | 2013-06-06 |
JP6101077B2 JP6101077B2 (ja) | 2017-03-22 |
Family
ID=43011700
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012507283A Active JP6101077B2 (ja) | 2009-04-20 | 2010-04-19 | 生体分子を細胞へトランスフェクトするための組成物 |
JP2015171776A Expired - Fee Related JP6295235B2 (ja) | 2009-04-20 | 2015-09-01 | 生体分子を細胞へトランスフェクトするための組成物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015171776A Expired - Fee Related JP6295235B2 (ja) | 2009-04-20 | 2015-09-01 | 生体分子を細胞へトランスフェクトするための組成物 |
Country Status (7)
Country | Link |
---|---|
US (1) | US11738084B2 (ja) |
EP (1) | EP2421952B1 (ja) |
JP (2) | JP6101077B2 (ja) |
KR (1) | KR101742332B1 (ja) |
AU (1) | AU2010239463B2 (ja) |
HU (1) | HUE028642T2 (ja) |
WO (1) | WO2010123798A2 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6101077B2 (ja) * | 2009-04-20 | 2017-03-22 | ガレンバイオ、インコーポレイテッド | 生体分子を細胞へトランスフェクトするための組成物 |
JP6208767B2 (ja) * | 2012-10-23 | 2017-10-04 | エコール スペリュール デ フィジーク エ シミ アンドゥストリエル デ ラ ヴィル デ パリ | 複数回逐次的に形成し、切断することができる可逆的共有結合を含む粒子 |
CN103849650B (zh) * | 2013-10-14 | 2018-08-03 | 王深明 | 功能化纳米姜黄素的基因导入材料及制备方法 |
NZ745881A (en) | 2016-02-04 | 2023-04-28 | Auransa Inc | Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity |
CN108330102B (zh) * | 2018-03-14 | 2020-02-14 | 江南大学 | 一株泰妙菌素单克隆抗体杂交瘤细胞株及其应用 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4954515A (ja) | 1972-10-03 | 1974-05-27 | ||
US5602244A (en) | 1988-05-26 | 1997-02-11 | Competitive Technologies, Inc. | Polynucleotide phosphorodithioate compounds |
JP2524406B2 (ja) * | 1988-07-05 | 1996-08-14 | 田辺製薬株式会社 | パイロジェン定量方法 |
KR100191223B1 (ko) | 1989-07-28 | 1999-06-15 | 둘락 노먼 씨. | 인터루킨-4의 정제방법 및 이를 함유하는 약제학적 조성물 |
US6001982A (en) | 1993-07-29 | 1999-12-14 | Isis Pharmaceuticals, Inc. | Synthesis of oligonucleotides |
US5962674A (en) | 1995-06-01 | 1999-10-05 | Hybridon, Inc. | Synthesis of oligonucleotides containing alkylphosphonate internucleoside linkages |
JPH10510433A (ja) | 1995-06-06 | 1998-10-13 | アイシス・ファーマシューティカルス・インコーポレーテッド | 高いキラル純度のホスホロチオエート結合を有するオリゴヌクレオチド |
US5985662A (en) | 1995-07-13 | 1999-11-16 | Isis Pharmaceuticals Inc. | Antisense inhibition of hepatitis B virus replication |
US5734041A (en) | 1995-10-20 | 1998-03-31 | Mcgill University | Preparation of chiral phosphorothioate oligomers |
US6194469B1 (en) | 1998-12-11 | 2001-02-27 | Board Of Trustees Operating Michigan State Univeristy | Method for inhibiting cyclooxygenase and inflammation using cherry bioflavonoids |
IL144597A0 (en) * | 1999-02-03 | 2002-05-23 | Powderject Res Ltd | Hydrogel particle formulations |
US7195780B2 (en) * | 2002-10-21 | 2007-03-27 | University Of Florida | Nanoparticle delivery system |
WO2002002131A2 (en) | 2000-06-29 | 2002-01-10 | Corixa Corporation | Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
JP2005519990A (ja) * | 2001-10-12 | 2005-07-07 | ユニバーシティ オブ アイオワ リサーチ ファウンデーション | イミダゾキノリン化合物を用いて免疫応答を増強するための方法および産物 |
DE60304989T2 (de) | 2003-02-18 | 2007-03-29 | Clinique La Prairie Research S.A. | Zusammensetzungen enthaltend fötales Hämoglobin und bakterielles Endotoxin und fakultativ zusätzliche fötale Leberkomponenten |
US7785769B2 (en) * | 2003-07-25 | 2010-08-31 | The United States of America as reprsented by the Secretary of the Navy | Immobilization of oligonucleotides and proteins in sugar-containing hydrogels |
ZA200707249B (en) * | 2005-01-28 | 2010-08-25 | Galen Bio Inc | Immunologically active compositions |
US20070020620A1 (en) * | 2005-07-14 | 2007-01-25 | Finn M G | Compositions and methods for coupling a plurality of compounds to a scaffold |
US20070281036A1 (en) * | 2005-12-19 | 2007-12-06 | University Of Vermont And State Agricultural College | System and method of delivering a desired material to a cell |
US8288124B2 (en) * | 2008-11-20 | 2012-10-16 | Abbott Laboratories | Cloning, expression and purification of recombinant porcine intrinsic factor for use in diagnostic assay |
JP6101077B2 (ja) * | 2009-04-20 | 2017-03-22 | ガレンバイオ、インコーポレイテッド | 生体分子を細胞へトランスフェクトするための組成物 |
ES2397909B1 (es) * | 2011-05-05 | 2014-06-06 | Universidad De Zaragoza | Procedimiento de obtención de materiales multifuncionalizados |
-
2010
- 2010-04-19 JP JP2012507283A patent/JP6101077B2/ja active Active
- 2010-04-19 WO PCT/US2010/031559 patent/WO2010123798A2/en active Application Filing
- 2010-04-19 HU HUE10767573A patent/HUE028642T2/en unknown
- 2010-04-19 KR KR1020117027684A patent/KR101742332B1/ko active IP Right Grant
- 2010-04-19 AU AU2010239463A patent/AU2010239463B2/en not_active Ceased
- 2010-04-19 EP EP10767573.8A patent/EP2421952B1/en not_active Not-in-force
- 2010-04-19 US US13/264,814 patent/US11738084B2/en active Active
-
2015
- 2015-09-01 JP JP2015171776A patent/JP6295235B2/ja not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2021074025A5 (ja) | ||
JP2012524120A5 (ja) | ||
De Clercq | Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections | |
AR124140A2 (es) | Formulaciones de anticuerpos | |
Govorkova et al. | Combination chemotherapy for influenza | |
Bandara et al. | Pseudomonas aeruginosa lipopolysaccharide inhibits C andida albicans hyphae formation and alters gene expression during biofilm development | |
MX2011003843A (es) | Incorporacion de adyuvante en inmunonanoterapeuticos. | |
BR112014001907A2 (pt) | produção de dha e outros lc-pufas em plantas | |
EA200970273A1 (ru) | Применение 2-6-(3-аминопиперидин-1-ил)-3-метил-2,4-диоксо-3,4-дигидро-2н-пиримидин-1-илметил-4-фторбензонитрила | |
PE20230684A1 (es) | Analogos de carba-nucleosidos sustituidos con 2'-fluoro como inhibidores de la arn polimerasa | |
BRPI0516323A (pt) | construtos de rna | |
BR112015000710A8 (pt) | Oligonucleotídeos para fazer uma alteração na sequência de um presente alvo de molécula de rna em uma célula viva | |
Müller et al. | Morphogenetic (mucin expression) as well as potential anti-corona viral activity of the marine secondary metabolite polyphosphate on A549 cells | |
JP2013514797A5 (ja) | ||
JP2013508315A5 (ja) | ||
JP2015523072A5 (ja) | ||
JP2016510747A5 (ja) | ||
Paoletti et al. | Multifaceted roles of purinergic receptors in viral infection | |
WO2010123798A3 (en) | Compositions for transfection of biomolecules into cells | |
JP2010053122A5 (ja) | ||
JP2010536929A5 (ja) | ||
CL2014002896A1 (es) | Una formulacion farmaceutica en la forma de una tableta recubierta que consiste de a) un nucleo obtenido a partir de una co-mezcla de manitol, croscarmelosa de sodio y al menos un compuestos activo, y b) un recubrimiento el cual se aplica en la forma de una solucion acuosa o que contiene agua y alcohol, y donde la tableta se desintegra rapidamente en presencia de humedad; y su proceso de preparacion. | |
AU2016204400A1 (en) | Method of inducing an immune response | |
PE20140962A1 (es) | Una formulacion farmaceutica solida | |
WO2010132047A8 (en) | Guanosine/gmp gels and uses thereof |